SCHEMBL3215544

SCHEMBL3215544

CCOc1ccc(N(Cc2cnco2)c2ccc(C(=O)OC(C)(C)C)cc2)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
HPGD P15428 1/20 0.38
GPR119 Q8TDV5 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
AAK1 Q2M2I8 1/20 0.37
ALDH1A1 P00352 1/20 0.37
NAMPT P43490 1/20 0.36
IMPDH2 P12268 1/20 0.35
IMPDH1 P20839 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SREBF1 P36956 1/20 0.35
GRM7 Q14831 1/20 0.34
MAPT P10636 3/20 0.34
LMNA P02545 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
MCHR1 Q99705 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3201229 0.96 TP53 (0.38) TSHRMAPK1L3MBTL1HPGDGPR119
SCHEMBL3192199 0.95 HRH4 (0.39) MAPK1L3MBTL1HPGDGPR119HRH4
SCHEMBL3129701 0.92 SREBF1 (0.40) TSHRMAPK1L3MBTL1HPGDGPR119
SCHEMBL3214119 0.90 GPR119 (0.40) GPR119AAK1IMPDH2MCHR1
SCHEMBL3202834 0.90 RXRA (0.40) MAPK1GPR119HRH4AAK1ALDH1A1
SCHEMBL3123133 0.89 SREBF1 (0.37) TSHRMAPK1L3MBTL1HPGDGPR119
SCHEMBL3249961 0.88 GPR119 (0.39) GPR119AAK1NAMPTIMPDH2IMPDH1
SCHEMBL3126123 0.88 HRH4 (0.38) MAPK1GPR119HRH4AAK1NAMPT
SCHEMBL3200044 0.88 TSHR (0.52) TSHRMAPK1L3MBTL1HPGDHRH4
SCHEMBL3193658 0.88 POLB (0.40) TSHRMAPK1L3MBTL1GPR119AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B TSHR 1908/4885MAPK1 1371/4885L3MBTL1 3388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.